Standout Papers

Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacy 2018 2026 2020 2023 245
  1. Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacy (2018)
    Federico Rossari, Filippo Minutolo et al. Journal of Hematology & Oncology

Immediate Impact

1 from Science/Nature 58 standout
Sub-graph 1 of 22

Citing Papers

Unraveling the tumor microenvironment: Insights into cancer metastasis and therapeutic strategies
2024 Standout
Polyvinyl Alcohol (PVA)-Based Hydrogels: Recent Progress in Fabrication, Properties, and Multifunctional Applications
2024 Standout
1 intermediate paper

Works of Federico Rossari being referenced

Gene-based delivery of immune-activating cytokines for cancer treatment
2023
Targeted inducible delivery of immunoactivating cytokines reprograms glioblastoma microenvironment and inhibits growth in mouse models
2022

Author Peers

Author Last Decade Papers Cites
Federico Rossari 139 175 56 120 14 408
Markus Lindauer 96 171 81 59 17 396
Shashi Jatiani 166 157 62 70 13 372
Oliver Hiller 127 131 90 114 14 455
I Junghahn 128 209 116 81 23 448
François Béliveau 70 177 30 109 17 388
Scott K. Shore 88 282 41 125 15 441
Patricia Balsas 150 288 81 132 14 444
Kristina Sohlbach 98 149 99 130 17 340
Goar Mosoyan 82 198 36 195 16 414
Bettina Wingelhofer 121 198 93 73 12 365

All Works

Loading papers...

Rankless by CCL
2026